Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 12,660 | 11,600 | 12,090 |
| Receivables | 70 | 80 | 20 |
| Other current assets | 30 | 10 | 10 |
| TOTAL | $12,760 | $11,690 | $12,120 |
| Non-Current Assets | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Assets | $15,370 | $14,330 | $14,740 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 820 | 800 | 30 |
| Accrued Expenses | 720 | 750 | 40 |
| TOTAL | $1,540 | $1,560 | $80 |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | N/A | 100 |
| Other Non-Current Liabilities | 100 | 100 | 760 |
| TOTAL | $100 | $100 | $860 |
| Total Liabilities | $1,640 | $1,660 | $950 |
| Shareholders' Equity | |||
| Common Shares | 14,520 | 12,410 | 12,640 |
| Retained earnings | -2,480 | -1,430 | -580 |
| Other shareholders' equity | 0 | -10 | 0 |
| TOTAL | $13,720 | $12,660 | $13,780 |
| Total Liabilities And Equity | $15,360 | $14,320 | $14,730 |